Researchers have identified a form of B12 deficiency caused by autoantibodies that specifically affects the central nervous system. Discovered while studying a puzzling case of one...
LYON, France — The drug zodasiran (formerly ARO-ANG3), which targets the production of a liver protein, substantially lowers triglyceride and a range of lipoprotein levels in...
LYON, France — The first oral small molecule anti–proprotein convertase subtilisin kexin type 9 (PCSK9) inhibitor appears to be effective in not only lowering low-density lipoprotein...
LYON, France — Bempedoic acid ( Nexletol) is safe for people with obesity and is effective at lowering lipid levels and rates of major cardiovascular events,...
LYON, FRANCE — High levels of lipoprotein(a) [Lp(a)] in the blood are associated with a significantly increased risk for chronic kidney disease, report investigators who are...